European Internal Beam Radiotherapy/Brachytherapy Market Research Report
- Report Code: IN 1002
- Publish Date: Upcoming
The European internal beam radiotherapy market, mainly driven by rapidly changing cancer treatment technology and the growing number of cancer patients, was valued at $123.5 million in 2013, and expected to be $141.1 million by 2018, at a CAGR of 2.5%.
The report ‘European Internal Beam Radiotherapy Market forecast, 2012-2018’ analyzes the market of devices by segments such as brachytherapy seeds, applicators & afterloaders and electronic brachytherapy. Types of internal beam radiotherapy/brachytherapy are low dose rate and high dose rate. These segments are expected to experience a positive growth till 2018, with an increase in cancer patient pool, increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $68.8 million and $51.5 million, brachytherapy seeds and applicators & afterloaders segments are contributing 53% and 42% respectively in terms of total internal beam radiotherapy devices market. Both the markets have been witnessing maximum growth because of increase in cancer patient pool.
In Europe (Germany, France, Italy, Spain, UK), the rising rate of the cancer population have been driving the market growth. The market growth is significantly higher in North America because of its inclination to the newer techniques. The comparatively slow-moving markets such as Europe and Japan are maturing with both old and new technologies. North America is the most dynamic, highly competitive and the largest market for radiotherapy devices globally.
Internal beam radiotherapy market holds a minor share in the entire radiotherapy market, and is further shrinking due to non-supportive government reimbursement policy in the U.S. market. Beyond the U.S. market, Europe and the BRIC nations are the only potential markets to sustain this therapeutic procedure.
Prevalence of Cancer worldwide is around 7.4 million (53%) in males and 6.7 million (47%) in females, giving a male to female ratio of 10:9. In 2012, there were 14.1 million new cases of cancer in the world. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. Cancer remains the second most common cause of death in the US, accounting for nearly 1 of every 4 deaths.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in the internal beam radiotherapy market and extensively covered in this report are Elekta AB, Theragenics corp., C.R. Bard, Eckert & Ziegler BEBIG SA.
Segment and country specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country specific prevalence of prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, lung cancer, head and neck and esophagus cancer
- Country specific patient pool of prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, lung cancer, head and neck and esophagus cancer
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of prostate cancer, gynecology, breast, cervical, and head and neck cancers surgeries performed annually in each country tracked till sub-segment level
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of surgeons’ response to market events and trends
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/ Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of radiotherapy devices in European countries
- Prostate cancer, gynecology, breast, cervical, and head and neck cancers procedural investment in major countries
Competitive Intelligence
- The company share analysis of radiotherapy devices for the top players of the internal beam radiotherapy market in Europe
- The crucial developments and strategies of companies inculcating in their portfolio for the internal beam radiotherapy devices
Alternative Products: Impact analysis
MMM’S healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Radiotherapy Devices Market The North American Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1878.7 million in 2013 and expected to be $2072.9 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European Radiotherapy Devices Market The European Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $915.4 million in 2013 and expected to be $1028.1 million by 2018, growing at a CAGR of 2.3%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Asian Radiotherapy Devices Market The Asian Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $847.8 million in 2013 and expected to be $1107.8 million by 2018, growing at a CAGR of 5.5%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as External Beam Radiation Therapy, Internal Beam radiation Therapy, and Systemic radiation Therapy.The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
